Consistent with the negative regulatory role of LNK in hematopoiesis and the myeloproliferative phenotype of LNK-deficient mice, mutations in the SH2B3 gene have been reported in approximately 7% of PV patients [5,84]. The gene discussed is SH2B3; the disease is acquired polycythemia vera.